State-level tracking of COVID-19 in the United States.
Unwin HJT, Mishra S, Bradley VC, Gandy A, Mellan TA, Coupland H, Ish-Horowicz J, Vollmer MAC, Whittaker C, Filippi SL, Xi X, Monod M, Ratmann O, Hutchinson M, Valka F, Zhu H, Hawryluk I, Milton P, Ainslie KEC, Baguelin M, Boonyasiri A, Brazeau NF, Cattarino L, Cucunuba Z, Cuomo-Dannenburg G, Dorigatti I, Eales OD, Eaton JW, van Elsland SL, FitzJohn RG, Gaythorpe KAM, Green W, Hinsley W, Jeffrey B, Knock E, Laydon DJ, Lees J, Nedjati-Gilani G, Nouvellet P, Okell L, Parag KV, Siveroni I, Thompson HA, Walker P, Walters CE, Watson OJ, Whittles LK, Ghani AC, Ferguson NM, Riley S, Donnelly CA, Bhatt S, Flaxman S.
Unwin HJT, et al.
Nat Commun. 2020 Dec 3;11(1):6189. doi: 10.1038/s41467-020-19652-6.
Nat Commun. 2020.
PMID: 33273462
Free PMC article.
We use changes in mobility to capture the impact that non-pharmaceutical interventions and other behaviour changes have on the rate of transmission of SARS-CoV-2. We estimate that R(t) was only below one in 23 states on 1st June. We also estimate that 3.7% [3.4%-4.0%] of t …
We use changes in mobility to capture the impact that non-pharmaceutical interventions and other behaviour changes have on the rate of trans …